IP Library Patent Application 13505348
Patent Application
App. No. 13/505,348

USE OF YEAST PEPTIDE HYDROLYSATE AS AN ACTIVE AGENT FOR STRENGTHENING HAIR

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/505,348
Filed
May 1, 2012
Art Unit
1654
USPC
514/20.7
Abstract

The invention concerns the use of a composition comprising at least one yeast ( Saccharomyces cerevisiae ) peptide hydrolysate as an active agent for strengthening hair and improving hair health. The invention also concerns the use of this novel active agent for making a dermo-pharmaceutical composition intended to stimulate hair growth or to prevent hair loss. The invention furthermore refers to a cosmetic treatment method intended to stimulate hair growth or counteract hair loss and counteract external aggressions affecting the hair.

Claims (15)

1 . Cosmetic use of a composition comprising at least one yeast ( Saccharomyces cerevisiae ) peptide hydrolysate, obtained by cells disruption and elimination of most of the insoluble membrane components, as an active agent for strengthening hair and improving hair health.

2 . A use according to claim 1 , characterized in that the peptide hydrolysate has a protein concentration of 30% to 70% of the total weight of the dry extract, and more specifically 40% to 50% of the total weight of the dry extract.

3 . A use according to claim 1 , characterized in that the peptide hydrolysate is dissolved in one or more physiologically acceptable solvents, such as water, glycerol, ethanol, propanediol, butylene glycol, dipropylene glycerol, ethoxylated or propoxylated diglycols, cyclic polyhydric alcohols, or any mixture of these solvents.

4 . A use according to claim 1 , characterized in that the peptide hydrolysate is used in a quantity of 0.001% to 5% of the total weight of the composition, and preferably in a quantity of 0.01% to 1% of the total weight of the composition.

5 . A use according to claim 1 , characterized in that the composition is in a form suitable for topical application having a physiologically acceptable medium.

6 . A use according to claim 1 , characterized in that the composition furthermore comprises at least one other active agent which protects or improves hair growth and/or health.

7 . A use according to claim 1 to counteract alopecia.

8 . A cosmetic use of a peptide hydrolysate as an active agent as defined in claim 1 , to strengthen the hair follicle structures.

9 . A use according to claim 8 , characterized in that the active agent increases the expression of keratin 14 and keratin K17 in the external sheath cells of the hair follicle.

10 . A use according to claim 8 , characterized in that the active agent increases the expression of collagen IV and protein CD34 in the wall of the hair follicle blood vessels.

11 . A use according to claim 8 , characterized in that the active agent increases the expression of collagen I in the conjunctive tissue sheath and dermal papilla of the hair follicle.

12 . A method of cosmetic treatment intended to restore and/or stimulate hair growth, or counteract hair loss, characterized in that a composition as defined in claim 1 is applied topically to the area being treated.

13 . A method of cosmetic treatment intended to restore and/or stimulate eyelash growth, or counteract eyelash loss, characterized in that a composition as defined in claim 1 is applied topically to the area being treated.

14 . A use of a yeast peptide hydrolysate as defined in claim 1 as an active agent capable of strengthening and protecting the hair follicle, for the preparation of a dermo-pharmaceutical composition intended to stimulate hair growth or prevent hair loss related to a pathological condition.

15 . A use according to the claim 14 , characterized in that the pathological conditions are alopecia areata, the side effects of drug treatments, and certain infections or inflammations of the scalp.

Assignments (4)
RELEASE OF PATENT SECURITY AGREEMENT Recorded Mar 18, 2013
From: THE BANK OF NOVA SCOTIA
To: ASHLAND LICENSING AND INTELLECTUAL PROPERTY LLC; AQUALON COMPANY; ISP INVESTMENTS INC.; HERCULES INCORPORATED
Reel/Frame 030025/0320 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 20, 2012
From: DAL FARRA, CLAUDE; DOMLOGE, NOUHA; BOTTO, JEAN-MARIE
To: ISP INVESTMENTS INC.
Reel/Frame 029509/0157 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 26, 2012
From: DAL FARRA, CLAUDE; DOMLOGE, NOUHA; BOTTO, JEAN-MARIE
To: ISP INVESTMENTS INC.
Reel/Frame 029196/0745 →
SECURITY AGREEMENT Recorded May 22, 2012
From: HERCULES INCORPORATED; ISP INVESTMENTS INC.
To: THE BANK OF NOVA SCOTIA
Reel/Frame 028252/0499 →